Plums, have you tried Renovo for a response. Like a dog with a...

Plums, have you tried Renovo for a response.
Like a dog with a bone, I can't let this go.
After Ryans appointment as Senior Vice President, Head of Corporate Strategy and Partnerships & with everything going on in the Renovo camp why did he choose to pick Imugene out in his quote

“RenovoRx is at an important juncture, and I am excited to step into this role on a permanent basis,” said Mr. Witt. “Building off our collaboration with Imugene and clinical data delivering gemcitabine with our drug-delivery platform, there is incredible potential for RenovoRx’s technology.
Ryan Witt

Right or wrong we have a proxy listing on the Nasdaq in RenovoRx, the oncology world will be watching IMU if this eventuates.
RNXT up 6% on the news.
imo dyor
Foil hat off.